These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 15689159)

  • 1. Surface plasmon resonance thermodynamic and kinetic analysis as a strategic tool in drug design. Distinct ways for phosphopeptides to plug into Src- and Grb2 SH2 domains.
    de Mol NJ; Dekker FJ; Broutin I; Fischer MJ; Liskamp RM
    J Med Chem; 2005 Feb; 48(3):753-63. PubMed ID: 15689159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamic and structural analysis of phosphotyrosine polypeptide binding to Grb2-SH2.
    McNemar C; Snow ME; Windsor WT; Prongay A; Mui P; Zhang R; Durkin J; Le HV; Weber PC
    Biochemistry; 1997 Aug; 36(33):10006-14. PubMed ID: 9254595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin.
    Shi YH; Song YL; Lin DH; Tan J; Roller PP; Li Q; Long YQ; Song GQ
    Biochem Biophys Res Commun; 2005 May; 330(4):1254-61. PubMed ID: 15823578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual specificity of Src homology 2 domains for phosphotyrosine peptide ligands.
    Gay B; Furet P; García-Echeverría C; Rahuel J; Chène P; Fretz H; Schoepfer J; Caravatti G
    Biochemistry; 1997 May; 36(19):5712-8. PubMed ID: 9153411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing alpha-methylphenylalanyl based phosphotyrosyl mimetics.
    Oishi S; Karki RG; Kang SU; Wang X; Worthy KM; Bindu LK; Nicklaus MC; Fisher RJ; Burke TR
    J Med Chem; 2005 Feb; 48(3):764-72. PubMed ID: 15689160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
    Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
    J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the "two-pronged plug two-holed socket" model for the mechanism of binding of the Src SH2 domain to phosphotyrosyl peptides: a thermodynamic study.
    Bradshaw JM; Grucza RA; Ladbury JE; Waksman G
    Biochemistry; 1998 Jun; 37(25):9083-90. PubMed ID: 9636054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and biological evaluation of linear and cyclic phosphopeptide ligands of the N-terminal SH2 domain of protein tyrosine phosphatase SHP-1.
    Imhof D; Wieligmann K; Hampel K; Nothmann D; Zoda MS; Schmidt-Arras D; Zacharias M; Böhmer FD; Reissmann S
    J Med Chem; 2005 Mar; 48(5):1528-39. PubMed ID: 15743195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of binding energies of SrcSH2-phosphotyrosyl peptides with structure-based prediction using surface area based empirical parameterization.
    Henriques DA; Ladbury JE; Jackson RM
    Protein Sci; 2000 Oct; 9(10):1975-85. PubMed ID: 11106171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of water in computational and experimental derivation of binding thermodynamics in SH2 domains.
    Geroult S; Virdee S; Waksman G
    Chem Biol Drug Des; 2006 Jan; 67(1):38-45. PubMed ID: 16492147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grb2 SH2 domain-binding peptide analogs as potential anticancer agents.
    Lung FD; Tsai JY
    Biopolymers; 2003; 71(2):132-40. PubMed ID: 12767115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Src homology-2 domain binding assays by scintillation proximity and surface plasmon resonance.
    Mandine E; Gofflo D; Jean-Baptiste V; Sarubbi E; Touyer G; Deprez P; Lesuisse D
    J Mol Recognit; 2001; 14(4):254-60. PubMed ID: 11500972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands.
    Yao ZJ; King CR; Cao T; Kelley J; Milne GW; Voigt JH; Burke TR
    J Med Chem; 1999 Jan; 42(1):25-35. PubMed ID: 9888830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics, free energy, and SPR analyses of the interactions between the SH2 domain of Grb2 and ErbB phosphotyrosyl peptides.
    Suenaga A; Hatakeyama M; Ichikawa M; Yu X; Futatsugi N; Narumi T; Fukui K; Terada T; Taiji M; Shirouzu M; Yokoyama S; Konagaya A
    Biochemistry; 2003 May; 42(18):5195-200. PubMed ID: 12731860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors to the Src SH2 domain: a lesson in structure--thermodynamic correlation in drug design.
    Henriques DA; Ladbury JE
    Arch Biochem Biophys; 2001 Jun; 390(2):158-68. PubMed ID: 11396918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic phosphopeptides for interference with Grb2 SH2 domain signal transduction prepared by ring-closing metathesis and phosphorylation.
    Dekker FJ; de Mol NJ; Fischer MJ; Kemmink J; Liskamp RM
    Org Biomol Chem; 2003 Oct; 1(19):3297-303. PubMed ID: 14584793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of a beta-aminophosphotyrosyl mimetic in the design and synthesis of macrocyclic Grb2 SH2 domain-binding peptides.
    Lee K; Zhang M; Liu H; Yang D; Burke TR
    J Med Chem; 2003 Jun; 46(13):2621-30. PubMed ID: 12801226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands.
    Rahuel J; García-Echeverría C; Furet P; Strauss A; Caravatti G; Fretz H; Schoepfer J; Gay B
    J Mol Biol; 1998 Jun; 279(4):1013-22. PubMed ID: 9642078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and conformational requirements for high-affinity binding to the SH2 domain of Grb2(1).
    Ettmayer P; France D; Gounarides J; Jarosinski M; Martin MS; Rondeau JM; Sabio M; Topiol S; Weidmann B; Zurini M; Bair KW
    J Med Chem; 1999 Mar; 42(6):971-80. PubMed ID: 10090780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.